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Abstract 
Purpose: Acute respiratory distress syndrome (ARDS) is an acute inflammatory lung injury 
that frequently shows fatal outcomes. As radiographic predictive factors, some reports have 
focused on the region of ill-aerated lung, but none have focused on well-aerated lung. Our 
objective was to evaluate the relationship between computed tomography (CT) volume of the 
well-aerated lung region and prognosis in patients with ARDS.  
Method: This retrospective observational study of a single intensive care unit (ICU) included 
patients with ARDS treated between April 2011 and May 2013. We identified 42 patients with 
ARDS for whom adequate helical CT scans were available. CT images were analyzed for 3-
dimensional reconstruction, and lung region volumes were measured using automated 
volumetry methods. Lung regions were identified by CT attenuation in Hounsfield units (HU). 
Results: Of the 42 patients, 35 (83.3%) survived 28 days and 32 (76.2%) survived to ICU 
discharge. CT lung volumetry was performed within 144.5 ± 76.6 seconds, and inter-rater 
reliability of CT lung volumetry for lung regions below -500 HU (well-aerated lung region) 
were near-perfect. Well-aerated lung region showed a positive correlation with 28-day survival 
(P=0.020), and lung volumes below -900 HU correlated positively with 28-day survival and 
ICU survival, respectively (P=0.028, 0.017). Survival outcome was better for percentage of 
well-aerated lung region/predicted total lung capacity ≥40% than for <40% (P=0.039). 
Conclusions: CT lung volumetry of the well-aerated lung region using an automated method 
allows fast, reliable quantitative CT analysis and potentially prediction of the clinical course in 
patients with ARDS. 
  
  
 
Background 
Acute respiratory distress syndrome (ARDS) is an acute inflammatory lung injury 
characterized by increases in pulmonary vascular permeability and extravascular lung water 
and decreases in aerated lung area, and frequently displays fatal outcomes [1,2]. Although 
previous studies have provided substantial insights into ARDS, limited information has been 
accumulated regarding epidemiology, recognition, management, and outcomes for patients 
with ARDS. Several predictors of mortality for ARDS have been reported, but no predictive 
factors have been established in guidelines for the management of ARDS [1,3]. 
Computed tomography (CT) can reflect pathological changes in the lung and reveal 
morphological features of lung diseases. In the Berlin definition [1], as the standard criterion 
for diagnosing ARDS, CT findings such as increased pulmonary vascular permeability and loss 
of aerated lung tissue are hallmarks of ARDS. Several investigations have revealed the 
possibility of predicting mortality for ARDS [4-6]. Those studies focused on ill-aerated lung 
regions on CT, reflecting fibroproliferative changes pathologically, but applied only subjective, 
visual-based evaluations by radiologists.  
As an objective method of lung analysis, estimation of lung volumes has been used in 
patients with various lung disease, including asthma, chronic obstructive pulmonary disease 
(COPD), interstitial lung diseases, and oncological diseases [7]. Nowadays, to achieve 
objective and speedy assessments, methods of automated lung CT segmentation have become 
extensively available [8, 9]. However, automated lung segmentation for ARDS is generally 
difficult to perform, because non-aerated lung areas are hard to differentiate from close CT-
dense structures such as the chest wall and mediastinum [10]. Manual methods allow 
segmentation of non-aerated lung areas, but estimation of lung volumes using manual 
processes does not show good reproducibility and are strongly dependent on the clinical 
  
expertise of the rater in routine clinical applications [11]. Otherwise, automated lung CT 
segmentation would allow fast, reliable quantitative analysis of well-aerated lung regions 
[11,12].  
The extent of well-aerated lung is a well-known predictor of complications in the 
perioperative phase of lung cancer surgery [13,14]. However, the region of well-aerated lung 
has not been focused on as a predictor of outcomes in patients with ARDS. We hypothesized 
that the volume of well-aerated lung would be related to mortality in patients with ARDS, and 
an approach using this relationship would allow the establishment of rapid, objective 
assessments. We estimated the volume of well-aerated lung in patients with ARDS using an 
automated CT volumetry method. The main goal of this study was to evaluate the relationship 
between CT volumes of well-aerated lung and prognosis in patients with ARDS. 
 
Methods 
Subjects 
This study was approved by the ethics committee of our institute and the need to obtain 
written informed consent was waived because of the retrospective study design (approval 
number: 2903). We initially assessed all 49 patients who had been hospitalized in the intensive 
care unit (ICU) of our institute between April 2011 and March 2013 who met the Berlin 
criteria for ARDS [1]. Exclusion criteria comprised: age <18 years (n=1); lack of adequate CT 
images (0.5-mm or 1.0-mm slice images; n=4); lack of adequate clinical data (height, which is 
needed to calculate predicted total lung capacity (pTLC); n=2); severe emphysema (n=0); and 
pregnancy (n=0). In total, 7 patients were excluded, and the remaining 42 patients were 
enrolled. We continued follow-up of patients until 56 days after diagnosis. 
 
Clinical parameters 
  
We assessed the following variables from medical charts: age; sex; height; body weight; 
body mass index (BMI); mean acute physiology and chronic health evaluation (APACHE) II 
score; sequential organ failure assessment (SOFA) score; primary cause of ARDS; arterial 
partial pressure of oxygen (PaO2)/fraction of inspired oxygen (FIO2) ratio; and severity of 
ARDS. We collected the following outcomes from medical charts: 1) survival at 7 days, 14 
days, 28 days, and 56 days; and 2) ICU survival (discharge from the ICU ≤ 56 days after 
diagnosis). 
 
Multidetector row computed tomography (MDCT) 
All patients underwent MDCT (Aquilion 64® or Aquilion ONE®; Canon Medical 
Systems, Tochigi, Japan) from the thoracic inlet to the diaphragm at the time of diagnosis. No 
contrast medium was used. MDCT scan parameters were as follows: helical mode; collimation, 
0.5 mm; tube voltage, 120 kV; gantry rotation time, 0.5 seconds; use of automatic exposure 
control; slice thickness, 0.5 mm; helical pitch, 65; and pitch factor, 0.83. A whole-lung CT 
scan was performed at full inspiration, sustained by a portable ventilator (Oxylog® 3000 Plus, 
Dräger, Medical Japan Ltd, Tokyo, Japan) with the same settings as applied in the ICU. All 
images were reconstructed using standard reconstruction algorithms with a slice thickness of 
0.5 mm or 1.0 mm and a reconstruction interval of 0.5 mm or 1.0 mm. 
 
CT volumetry 
CT lung volumetry was performed by delineation of lung regions of interest within each 
lung CT slice using a VirtualPlace Fujin Raijin 360 ® version 3.6009 workstation (AZE, 
Kanagawa, Japan). We used automated lung volumetry software with a region-growing 
algorithm. Hilar structures of the lung, trachea, and main bronchus were eliminated using 
manual methods, as needed. Lung regions were classified into 4 categories by CT attenuation 
  
densities: 1) hyperinflated, density between -1000 and -901 Hounsfield units (HU); 2) 
normally aerated, density between -900 and -501 HU; 3) poorly aerated, density between -500 
and -101 HU; and 4) non-aerated, density between +100 and -100 HU [12]. To certify 
reproducibility, a radiologist (A.N.) and a respiratory physician (N.K.) created 3-dimensional 
images and editing for volumetry. The volume of each lung region was divided by pTLC to 
correct for differences in physique among patients [15]. We considered hyperinflated and 
normally aerated regions (density below -500 HU) as well-aerated lung regions for this study 
and defined the well-aerated group and less-aerated group based on the median percentage of 
well-aerated lung region/pTLC.  
 
Statistical analysis 
Data are expressed as mean (±standard deviation). After confirming and examining that 
parameters were normally distributed, all following comparisons were performed using the 
Mann-Whitney U test as appropriate. Fisher's exact test was used to compare severity of 
ARDS, primary cause of ARDS, and treatment with methylprednisolone between 28-day 
survivors and non-survivors, and ICU survivors and non-survivors, respectively. To assess 
inter-rater reliability of CT lung volumes, the intraclass correlation coefficient (ICC) was 
calculated using a two-way random-effects model. CT lung volumes and clinical parameters 
were compared between 28-day survivors and non-survivors, and between ICU survivors and 
non-survivors using the Mann-Whitney U test. Relationships between CT lung volumes and 
28-day mortality were assessed using Kaplan-Meier methods and comparisons were performed 
using log-rank testing. For all statistical analyses, the level of significance was set at values of 
P<0.05. All statistical analyses were performed using JMP version 13.0 software (SAS 
Institute, Cary, NC). 
 
  
Results 
Patient characteristics 
The clinical parameters of the 42 patients (28 men, 14 women) are shown in Table 1. Mean 
age was 64.2 ± 17.1 years. Mean BMI was 22.8 ± 5.3 kg/m2. Mean APACHE II score was 30.2 
± 9.5 and mean SOFA score was 10.3 ± 4.3. Mean PaO2/ FIO2 ratio was 125.1 ± 57.7. Severity 
of ARDS was as follows: mild (n=3), 7.1%; moderate (n=21), 50.0%; and severe (n=18), 
42.9%. Primary cause of ARDS was pneumonia (n=9, 21.4%), sepsis (n=7, 16.7%), trauma 
(n=2, 4.8%), surgery (n=5, 11.9%), aspiration (n=10, 23.8%), and others (n=9, 21.4%). 
Prognosis was as follows: 40 of 42 patients (95.2%) survived to 14 days, 35 of 42 patients 
(83.3%) survived to 28 days, and 31 of 42 patients (73.8%) survived to 56 days. Of the 42 
patients, 32 (76.2%) survived to ICU discharge. Neither severity of ARDS nor primary cause 
of ARDS displayed any significant relationship with 28-day survival (P=0.835) or ICU 
survival (P=0.105), respectively. All patients underwent treatment with mechanical ventilatory 
support using a low tidal volume of 6-8 mL/kg and positive end-expiratory pressure (PEEP) 
within the range of plateau pressures 20 cmH2O (lower PEEP) and adequate antibiotic 
therapy. Twenty of the 42 patients (47.6%) underwent treatment with intravenously 
administered corticosteroids, such as low-dose methylprednisolone (1-2 mg/kg body 
weight/day). No significant differences in 28-day survival (P=0.229) or ICU survival 
(P=0.477) were evident between groups with and without intravenous methylprednisolone. No 
patients were treated with prone positioning. 
 
CT measurements 
CT lung volumetry was performed within 144.5 ± 76.6 seconds (range: 92-519 seconds). 
The results of CT measurement are shown in Table 2. CT lung region volumes were as 
follows: total lung, 2754.8 ± 851.9 mL; well-aerated lung, 2166.0 ± 828.8 mL; hyperinflated 
  
lung, 312.1 ± 401.3 mL; normally aerated lung, 1853.8 ± 603.4 mL; poorly aerated lung, 520.9 
± 298.1 mL; non-aerated lung, 46.0 ± 42.2 mL. ICCs between the two raters for lung region 
volumes were as follows: total lung, 0.92 [95% confidence interval 0.85 – 0.96]; well-aerated 
lung, 0.99 [0.98 – 0.99]; hyperinflated lung, 0.99 [0.98 – 1.00]; normally aerated lung, 0.97 
[0.95 – 0.99]; poorly aerated lung, 0.99 [0.83 – 0.95]; and non-aerated lung, 0.02 [-0.24 – 
0.30]. CT lung region volumes corrected to pTLC were as follows: total lung volume/pTLC, 
55.23 ± 16.34%; well-aerated lung/pTLC, 40.13 ± 16.57%; hyperinflated lung/pTLC, 6.16 ± 
7.65%; normally aerated lung/pTLC, 37.25 ± 12.45%; poorly aerated lung/pTLC, 10.50 ± 
6.01%; and non-aerated lung/pTLC, 0.89 ± 0.74%. Representative colormap 3-dimensional 
images of 28-day survivors and non-survivors are shown in Figure 1. 
 
Correlations between clinical parameters, CT measurements, and prognosis 
Correlations between clinical parameters and survival outcomes, and between CT 
measurements and survival outcomes, are shown in Tables 1 and 2, respectively. The PaO2/ 
FIO2 ratio of ICU survivors (132.4 ± 50.4) was significantly higher than that of ICU non-
survivors (101.9 ± 71.7; P=0.040). Total lung volumes (2896.4 ± 817.0 mL), well-aerated lung 
volumes (2317.9 ± 798.8 mL), hyperinflated lung volumes (361.0 ± 420.5 mL), and normally 
aerated lung volumes (1956.9 ± 582.7 mL) were higher in 28-day survivors than in 28-day 
non-survivors (2046.8 ± 644.5 mL, P=0.018; 1406.3 ± 488.1 mL, P=0.005; 67.6 ± 103.5 mL, 
P=0.015; and 1338.6 ± 410.6 mL, P=0.011), respectively. Also, well-aerated lung volumes 
(2320.7 ± 818.5 mL) and hyperinflated lung volumes (387.5 ± 430.2 mL) were higher in ICU 
survivors than in ICU non-survivors (1670.8 ± 647.4 mL, P=0.026; and 71.0 ± 89.4 mL, 
P=0.013, respectively). Well-aerated lung region/pTLC was significantly higher for 28-day 
survivors (45.99 ± 16.58%) than for 28-day non-survivors (30.46 ± 8.49%; P=0.020), and 
well-aerated lung region/pTLC for ICU survivors (45.91 ± 17.34%) showed no significant 
  
difference from that of ICU non-survivors (35.37 ± 10.33%; P=0.065). Also, hyperinflated 
area/pTLC of 28-day survivors (7.13 ± 7.99%) and ICU survivors (7.66 ± 8.16%) were higher 
than those of 28-day non-survivors (1.26 ± 1.78%; P=0.028) and ICU non-survivors (1.35 ± 
1.53%; P=0.017), respectively (Figure 2). No other factors showed any significant 
relationships with prognosis. 
The median percentage of well-aerated lung region/pTLC was 40.13%, which was used as 
the threshold for dividing well-aerated and less-aerated group. Kaplan-Meier survival curves 
for the percentage of well-aerated lung region/pTLC about the median (≥40% vs. <40%) 
within 28 days are shown in Figure 3. Kaplan-Meier analysis for 28-day survival showed 
significant differences between the well-aerated group and the less-aerated group (log-rank 
test, P=0.039). 
  
 
Discussion 
The main findings of this study were that CT lung volumetry represents a reproducible 
assessment and is feasible without excessive effort in routine clinical settings. Patients with 
well-aerated lung region/pTLC ≥40% showed a better 28-day survival curve. 
In our study, interrater variability of CT lung volumetry for well-aerated lung was near-
perfect (0.98-0.99). High interrater reliability and high reproducibility were shown. In a past 
report, volumetric differences in automated CT lung volumetry between different software 
packages were small [7]. Moreover, CT lung volumetry and estimation of each lung region 
volumes were performed within about 3 min. Ichikado et al. reported that visual-based analysis 
of CT score predicted the prognosis of patients with ARDS and showed good interobserver 
variability (κ=0.75, 0.68-0.82, 0.63-0.83) [4-6]. However, visual-based analysis generally 
  
requires a long time to perform. Our methods are simple and could be performed with minimal 
effort. 
The group with well-aerated lung region/pTLC ≥40% showed better survival outcome. 
Some reports have noted that patients with large ill-aerated lung regions experience poorer 
prognosis than patients with small ill-aerated lung regions [4-6,16], but no reports have 
focused on the well-aerated lung region of patients with ARDS. This is the first report to 
describe the relationship between well-aerated lung region and prognosis in patients with 
ARDS. 
Pulmonary function parameters are considered as prognostic predictors of several lung 
conditions. The percentage of predicted forced expiratory in 1 s (FEV1.0) is a hallmark for 
obstructive pulmonary diseases, such as COPD and asthma. The percentage diffusing capacity 
of the lung for carbon monoxide (%DLCO) reflects the ability of the lungs to transfer gas from 
inhaled air into red blood cells in pulmonary capillaries, and declines in interstitial lung 
disease, emphysema, and pulmonary hypertension [17,18]. FEV1.0 <40% and %DLCO <40% 
indicate an increased risk of perioperative complications in lung cancer operations [13,14,19], 
and patients with idiopathic pulmonary hypertension and %DLCO <45% displayed worse 
exercise performance and a lower survival rate than patients with %DLCO ≥45% [20]. 
Moreover, among patients with COPD, high-resolution CT lung densities reflect respiratory 
function and dyspnea perception [21]. FEV1.0 correlates with CT lung volume below -900 HU 
in COPD and asthma [22,23]. Extensive abnormalities on HRCT were associated with lower 
DLCO in interstitial lung disease [24,25] . Volume of CT lung regions below -950 HU was 
associated with decreased DLCO in COPD [26]. The well-aerated region in ARDS was 
suggested to reflect pulmonary function, although performing respiratory function 
examinations is difficult in ARDS subjects. 
  
The value for hyperinflated region/pTLC correlated positively with both 28-day survival 
rate and ICU survival rate. In patients with COPD, the lung region below -900 HU (considered 
a hyperinflated lung) is considered the low attenuation area (LAA). The percentage of LAA is 
associated with poor prognosis [27]. On the other hand, in patients with ARDS, the alveolar 
recruitment area is associated with good prognosis [28]. Vieira et al. reported that a region with 
CT attenuation below -900 HU among patients with ARDS is an aeration-improved region on 
application of PEEP, and an alveolar recruitment area [29]. In this study, all patients underwent 
CT at full inspiration, sustained using a respiratory bag. The hyperinflated region is considered 
to correspond to an alveolar recruitment region. 
Clinical severity scores (APACHE II and SOFA) have been used to assess the severity of 
critically ill patients, showing relationships to the prognosis of patients with multi-organ 
dysfunction syndrome in previous studies, particularly for predicting discharge from hospital 
and long-term mortality [30-32]. On the other hand, these scores were not always suitable for 
use as short-term predictors [33-35]. The finding, that APACHE II and SOFA scores represent 
significant predictors for patients with ARDS in thus controversial. No definitive predictors for 
the clinical course of patients with ARDS have been identified, and further studies are needed 
to support and validate our findings in the near future. 
Mechanical ventilatory support with low tidal volume and low plateau pressure is strongly 
recommended as a treatment in the management of patients with ARDS [3,36,37]. In the 
present study, all patients were treated in this manner. Low-dose corticosteroid therapy is 
reportedly associated with reductions in mortality, duration of mechanical ventilation and 
length of stay in the ICU, but the available evidence remains contradictory [38-40]. No 
significant differences in 28-day survival or ICU survival were seen between patients with or 
without corticosteroid therapy in our results. All patients had been treated with antibiotic 
therapy because inappropriate or delayed antibiotics raise the risk and accelerate the 
  
progression of ARDS [41]. In recent studies, treatment using prone positioning for at least 12 
h/day has been strongly recommended [37], but this was not a well-established treatment 
during the study period, so no patients underwent such treatment. Gravity-dependent CT lung 
densities shift from dorsal to ventral when the patient is turned prone, and mean lung densities 
were gradually higher in the supine position than in the prone position [42]. In our study, no 
positional differences in CT lung densities were apparent. 
We applied a region-growing algorithm to delineate the lung area. This method utilizes a 
simple computation based on the density range of lung tissue and is widely employed in 
commercially available workstations. First, a seed point presenting with normal density is 
determined. Then, a 3-dimensional region is grown from the seed point to neighboring pixels 
presenting with similar density [43]. This approach works well for well-aerated lung regions 
theoretically [10], and interrater reliability was almost perfect in volumetry for hyperinflated 
lung and normally aerated lung using the region-growing algorithm [44]. However, automatic 
volumetry using the region-growing algorithm for the high-density lung region, which shows 
similar density to non-lung soft-tissue regions, and measurement of volumes for non-aerated 
regions might be problematic [44]. Examples include methods based on registration, adaptive 
border matching, texture analysis and deep learning [44-46], which may show some potential 
for correctly segmenting even poorly aerated and non-aerated regions. 
 
Limitations 
This study had several limitations that need to be considered when interpreting the results. 
First, because of the retrospective nature of the evaluation and the single-center design, several 
selection biases may have been at play in the present cohort. Second, the sample size was 
small. We hope to expand upon our findings another cohort study using a multi-center design 
with, a much larger number of subjects. Third, causes of ARDS were not evaluated, and 
patients with pulmonary and extrapulmonary ARDS were not identified. Fourth, we evaluated 
  
CT images in the early phase of patients with ARDS and did not evaluate CT images in the late 
phase or temporal changes in CT images. 
 
 
Conclusions 
In conclusion, our results demonstrate that CT lung volumetry of well-aerated lung (region 
below -500 HU) using an automated method allows fast, reliable quantitative CT analysis and 
might predict the clinical course in patients with ARDS. 
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Fig. 1. Colormap CT images of patients with ARDS. 
 
A1-A3: 28-day survivor; B1-B3: 28-day non-survivor. 
Green: hyperinflated region; Blue: normally aerated region; Yellow: poorly aerated region; 
Red: non-aerated region. 
  
  
Fig. 2. Dot-plot analysis of 28-day survival and ICU survival of patients with ARDS. 
 
A1: Well-aerated lung region/pTLC was significantly higher in 28-day survivors than in 28-
day non-survivors (P=0.020). 
B1 and B2: Hyperinflated area/pTLC was significantly higher in 28-day survivors and ICU 
survivors than in 28-day non-survivors (P=0.028) and ICU non-survivors (P=0.017), 
respectively. 
  
  
Fig. 3. Kaplan-Meier analysis for 28-day survival. 
 
Kaplan-Meier analysis shows significant differences in 28-day survival between well-aerated 
group (well-aerated lung region/pTLC ≥40%) and less-aerated group (well-aerated lung 
region/pTLC <40%) (log-rank test, P=0.039). 
 
 
  
Table 1. Comparison of patient characteristics between groups as divided by 28-day survival and ICU survival 
 Overall 28-day survival   ICU survival  
 
 Survival 
(n=35) 
Non-survival 
(n=7) 
  Survival 
(n=32) 
Non-Survival 
(n=10) 
 
 
mean ± SD mean ± SD mean ± SD P  mean ± SD mean ± SD P 
Sex (male/female) 28 (66.7%) / 
14 (33.3%) 
25 (71.4%) / 
10 (28.6%) 
3 (42.9%) / 
4 (57.1%) 
0.154  23 (71.9%) / 
9 (28.1%) 
5 (50.0%) / 
5 (50.0%) 
0.212 
Age (years) 64.2 ± 17.1 65.3 ± 16.5 58.6 ± 19.0 0.458  64.4 ± 17.5 63.6 ± 16.0 0.028 
Height (cm) 161.6 ± 8.6 162.3 ± 7.8 157.9 ± 10.9 0.408  163.5 ± 8.0 155.6 ± 7.7 0.028 
Body weight (kg) 60.2 ± 17.8 59.7 ± 17.9 62.6 ± 17.4 0.840  61.4 ± 19.5 56.6 ± 9.6 0.523 
BMI (kg/m2) 22.8 ± 5.3 22.4 ± 5.4 24.7 ± 4.1 0.237  22.7 ± 5.8 23.3 ± 2.9 0.460 
APACHE II score 30.2 ± 9.5 30.1 ± 9.1 30.7 ± 11.0 0.821  29.9 ± 8.1 31.2 ± 12.9 0.718 
SOFA score 10.3 ± 4.3 10. 1 ± 3.8 11.1 ± 6.0 0.720  9.8 ± 3.3 11.6 ± 6.2 0.527 
PaO2/ FIO2 ratio 125.1 ± 57.7 125.4 ± 52.7 123.7 ± 77.8 0.601  132.4 ± 50.4 101.9 ± 71.7 0.040 
Severity of ARDS (PaO2/ FIO2)         
Mild (201-300 mmHg) 3/42 (7.1%) 2/35 (5.7%) 1/7 (14.3%) 0.835  2/32 (6.3%) 1/10 (10.0%) 0.105 
Moderate (101-200 mmHg) 21/42 (50.0%) 18/35 (51.4%) 3/7 (42.9%)   19/32 (59.4%) 2/10 (20.0%)  
Severe (≤100 mmHg) 18/42 (42.9%) 15/35 (42.9%) 3/7 (42.9%)   11/32 (34.4%) 7/10 (70.0%)  
Primary cause of ARDS         
Pneumonia 9/42 (21.4%) 
7/35 (20.0%) 
2/7 (28.6%) 
0.250  7/32 (21.9%) 2/10 (10.0%) 0.425 
Sepsis 7/42 (16.7%) 
6/35 (17.1%) 
1/7 (14.3%) 
  4/32 (12.5%) 3/10 (30.0%)  
Surgery 5/42 (11.9%) 
4/35 (11.4%) 
1/7 (14.3%) 
  4/32 (12.5%) 1/10 (10.0%)  
Aspiration 10/42 (23.8%) 
10/35 (28.6%) 
0/7 (0.0%) 
  8/32 (25.0%) 2/10 (20.0%)  
Trauma 2/42 (4.8%) 
2/35 (5.7%) 
0/7 (0.0%) 
  2/32 (6.3%) 0/10 (0.0%)  
Others 9/42 (21.4%) 
6/35 (17.1%) 
3/7 (42.9%) 
  7/32 (21.9%) 2/10 (20.0%)  
ICU, intensive care unit; SD, standard deviation; BMI, body mass index; APACHE, acute physiology and chronic health evaluation; SOFA, sequential 
organ failure assessment; ARDS, acute respiratory distress syndrome; PaO2, arterial partial pressure of oxygen; FIO2, fraction of inspired oxygen 
Significant P values (< 0.05) are given in bold type.
  
 
 
Table 2. Comparison of CT measurements between groups as divided by 28-day survival and ICU survival 
 Overall 28-day survival   ICU survival  
 
 Survival 
(n=35) 
Non-survival 
(n=7) 
  Survival 
(n=32) 
Non-survival 
(n=10) 
 
 
mean ± SD mean ± SD mean ± SD P  mean ± SD mean ± SD P 
Total lung volumes (mL) 2754.8 ± 851.9 2896.4 ± 817.0 2046.8 ± 644.5 0.018  2900.0 ± 820.0 2290.1 ± 782.7 0.079 
Well-aerated lung volume (mL) 2166.0 ± 828.8 2317.9 ± 798.8 1406.3 ± 488.1 0.005  2320.7 ± 818.5 1670.8 ± 647.4 0.026 
Hyperinflated lung volume (mL) 312.1 ± 401.3 361.0 ± 420.5 67.6 ± 103.5 0.015  387.5 ± 430.2 71.0 ± 89.4 0.013 
Normally aerated lung volume (mL) 1853.8 ± 603.4 1956.9 ± 582.7 1338.6 ± 410.6 0.011  1933.2 ± 581.2 1599.7 ± 602.9 0.111 
Poorly aerated lung volume (mL) 520.9 ± 298.1 507.1 ± 301.9 589.6 ± 267.4 0.380  507.2 ± 298.0 564.5 ± 294.0 0.647 
Non-aerated lung volume (mL) 46.0 ± 42.2 46.4 ± 43.5 43.6 ± 35.4 0.544  45.9 ± 44.9 46.2 ± 32.1 0.988 
         
Total lung/pTLC (%) 55.23 ± 16.34 57.37 ± 16.4 44.56 ± 11.02 0.098  57.26 ± 17.02 48.7 ± 11.8 0.209 
Well-aerated lung /pTLC (%) 40.13 ± 16.57 45.99 ± 16.58 30.46 ± 8.49 0.020  45.91 ± 17.34 35.37 ±10.33 0.065 
Hyperinflated lung/pTLC (%) 6.16 ± 7.65 7.13 ± 7.99 1.26 ± 1.78 0.028  7.66 ± 8.16 1.35 ± 1.53 0.017 
Normally aerated lung/pTLC (%) 37.25 ± 12.45 38.86 ± 12.58 29.19 ± 7.72 0.068  38.26 ± 12.98 34.0 ± 9.89 0.375 
Poorly aerated lung/pTLC (%) 10.50 ± 6.01 9.98 ± 5.76 13.08 ± 6.57 0.140  9.94 ± 5.73 12.27 ± 6.54 0.247 
Non-aerated lung/pTLC (%) 0.89 ± 0.74 0.90 ± 0.77 0.87 ± 0.59 0.607  0.88 ± 0.79 0.93 ± 0.53 0.505 
ICU, intensive care unit; SD, standard deviation; pTLC, predicted total lung capacity. 
Significant P values (< 0.05) are given in bold type. 
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